Koyfin Home > Directory > Health Care > Akebia Therapeutics > Price / Book

Akebia Therapeutics Price / Book Chart (AKBA)

Akebia Therapeutics annual/quarterly Price / Book from 2014 to 2020. Price-to-book value (P/B) is the ratio of market value of a company's shares (share price) over its book value of equity. The book value of equity, in turn, is the value of a company's assets expressed on the balance sheet.
  • Akebia Therapeutics Price / Book for the quarter ending September 09, 2020 was 1.14 a 8.47% increase of 0.10 year over year
  • Akebia Therapeutics Price / Book for the last 12 months ending September 09, 2020 was 1.14 a 8.47% increase of 0.10 year over year
  • Akebia Therapeutics Annual Price / Book for 2020 was 1.14 a 9.49% increase of 0.11 from 2019
  • Akebia Therapeutics Annual Price / Book for 2020 was 1.03 a 1.12% increase of 0.01 from 2019
  • Akebia Therapeutics Annual Price / Book for 2020 was 1.02 a -2.27% decrease of -0.02 from 2019
Other Valuation Metrics:
  • Akebia Therapeutics Market Cap for the quarter ending March 03, 2018 was $535m a -24.92% decrease of -133m year over year
  • Akebia Therapeutics Enterprise Value for the quarter ending March 03, 2018 was $217m a -91.84% decrease of -199m year over year
View Chart On Koyfin

Quarterly AKBA Price / Book Data

09/20201.14
09/20201.03
09/20201.02
09/20201.04
09/20200.98
09/20201.01
09/20201.02
09/20201.01
09/20201.05
09/20201.02

Annual AKBA Price / Book Data

20201.14
20201.03
20201.02
20201.04
20200.98
20201.01
20201.02
20201.01
20201.05
20201.02